B
Braidwell Portfolio holdings
AUM
$2.92B
1-Year Est. Return
4.59%
1 Year Est. Return
-4.59%
AUM
$2.92B
AUM Growth
+$79.1M
(+2.8%)
Holding
71
Top Buys
| 1 | +$195M | |
| 2 | +$45M | |
| 3 | +$36.1M | |
| 4 |
Inspire Medical Systems
INSP
|
+$28.5M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$28M |
Top Sells
| 1 | +$80.4M | |
| 2 | +$39.5M | |
| 3 | +$38.9M | |
| 4 |
BCAX
Bicara Therapeutics
BCAX
|
+$28.2M |
| 5 |
Guardant Health
GH
|
+$25.5M |
Sector Composition
| 1 | Healthcare | 71.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
1
Caris Life Sciences
CAI
$8.99B
| $195M | 6.69% |
+7,316,142
|
|
||
2
Neurocrine Biosciences
NBIX
$13.6B
| $146M | 4.99% |
1,160,425
-31,500
|
|
||
|
3
Xenon Pharmaceuticals
XENE
$3.25B
| $113M | 3.86% |
3,605,029
+895,154
|
|
||
4
argenx
ARGX
$51.6B
| $107M | 3.67% |
194,491
+33,642
|
|
||
5
Krystal Biotech
KRYS
$5.45B
| $100M | 3.42% |
727,811
+327,067
|
|
||
6
Align Technology
ALGN
$9.41B
| $94M | 3.22% |
496,730
-33,800
|
|
||
7
Legend Biotech
LEGN
$5.97B
| $90.2M | 3.09% |
2,542,104
-435,847
|
|
||
8
Nuvalent
NUVL
$6.52B
| $89.7M | 3.07% |
1,175,876
+334,931
|
|
||
9
CG Oncology
CGON
$3.19B
| $85.4M | 2.92% |
3,283,317
|
|
||
10
Edgewise Therapeutics
EWTX
$1.61B
| $68.3M | 2.34% |
5,210,831
+2,752,023
|
|
||
|
11
Inspire Medical Systems
INSP
$2.29B
| $67.8M | 2.32% |
522,410
+220,000
|
|
||
12
Apogee Therapeutics
APGE
$3.61B
| $64.2M | 2.2% |
1,478,512
-61,850
|
|
||
13
Glaukos
GKOS
$4.89B
| $62.3M | 2.13% |
603,414
-21,021
|
|
||
14
Danaher
DHR
$151B
| $61.1M | 2.09% |
309,339
|
|
||
15
Thermo Fisher Scientific
TMO
$203B
| $54.8M | 1.88% |
135,233
+7,500
|
|
||
16
Intuitive Surgical
ISRG
$156B
| $48.7M | 1.67% |
89,600
+1,600
|
|
||
17
iRhythm Technologies
IRTC
$5.82B
| $46.2M | 1.58% |
300,029
-256,362
|
|
||
18
Adaptive Biotechnologies
ADPT
$2.63B
| $45M | 1.54% |
3,863,107
-940,687
|
|
||
|
19
Guardant Health
GH
$8.41B
| $43.6M | 1.49% |
837,800
-489,527
|
|
||
20
Alphatec Holdings
ATEC
$2.11B
| $40.4M | 1.38% |
3,635,172
-624,257
|
|
||
21
Spyre Therapeutics
SYRE
$1.34B
| $38.6M | 1.32% |
2,578,404
|
|
||
22
Viking Therapeutics
VKTX
$3.91B
| $38.1M | 1.3% |
1,437,555
+1,600
|
|
||
23
Transmedics
TMDX
$3.94B
| $34.2M | 1.17% |
255,048
-599,836
|
|
||
24
Penumbra
PEN
$9.9B
| $33.3M | 1.14% |
129,628
+19,500
|
|
||
25
Dyne Therapeutics
DYN
$2.34B
| $31.2M | 1.07% |
3,273,349
-347,995
|
|